Table 4.
Antifungal activity of R. anthopogon essential oil, evaluated by microdilution assay.
| Clinical Strains | 24 h MIC (% v/v) | 48 h MIC (% v/v) |
|---|---|---|
| Candida albicans | 0.08-0.04 | 0.3-0.15 |
| C. albicans | 0.15 | 0.3 |
| C. albicans | 0.15 | 0.6 |
| C. albicans | 0.6-0.3 | 0.6 |
| C. albicans | 0.3 | 2.5 |
| C. albicans | 0.3 | 1.25 |
| Candida glabrata | 0.04 | 0.15 |
| C. glabrata | 0.15 | 0.6 |
| C. glabrata | 1.25 | 5 |
| C. glabrata | 2.5 | >5 |
| Candida tropicalis | 1.25-0.6 | 1.25 |
| C. tropicalis | 0.3 | 1.25 |
| Candida parapsilosis | 0.3 | 1.25 |
| C. parapsilosis | 0.3 | 0.6 |
| C. pseudotropicalis | 0.04 | 0.04 |
Miconazole MIC range: 0.125–64 g/mL; Amphotericin B MIC range: 0.25–4 g/mL.